GSK seeks preliminary approval of pandemic flu vaccine

01/7/2006 | Boston Globe (tiered subscription model), The

GlaxoSmithKline has applied to the European Medicines Agency for preliminary approval of a vaccine against pandemic influenza. Because companies cannot know in advance exactly which virus strain their vaccines may have to combat, the agency has established a "mockup" system so companies can start the approval process while still developing core vaccines.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX